Given that the crosstalk between Doxorubicin and TNF⍺ and the interplay between p53 and NFκB would occur in cells residing or infiltrating the tumor microenvironment, the ultimate in vivo outcome of these functional interactions may vary and cannot be directly predicted from our study using a pure culture of MCF7 cells in vitro. The gene discussed is TP53; the disease is neoplasm.